Lowering HbA1c in type 2 diabetics results in reduced risk of coronary heart disease and all-cause mortality - PubMed (original) (raw)

Review

Lowering HbA1c in type 2 diabetics results in reduced risk of coronary heart disease and all-cause mortality

Rien ten Brinke et al. Prim Care Diabetes. 2008 Feb.

Abstract

Aims: To assess to which extent lowering the level of HbA1c influences the 10-year risk of coronary heart disease (CHD) and all-cause mortality in patients with type 2 diabetes mellitus.

Methods: A literature search in Pubmed and Embase was performed, and the absolute risks in the results of the relevant and valid studies compared.

Results: Each study shows that with a decreasing percentage of HbA1c, both the risk of developing CHD and the risk of mortality decrease.

Conclusions: Lowering HbA1c in type 2 diabetics decreases the absolute risk of developing CHD by 5-17%, as well as decreasing all-cause mortality by 6-15%.

PubMed Disclaimer

Similar articles

Cited by

Publication types

MeSH terms

Substances

LinkOut - more resources